Philippe B.

Philippe B. has a diverse work experience spanning multiple companies and roles. Philippe currently serves as the Chief Scientific Officer at Oxurion NV, a position they have held since January 2024. Prior to this, they served as the Head of Preclinical and Translational Science at the same company from July 2021 to January 2024. Before joining Oxurion NV, Philippe held various positions at the company, including Head of Preclinical Operation from April 2017 to June 2021, Head of in vitro Pharmacology & Protein Science from April 2014 to March 2017, and Head of Protein Engineering from April 2003 to March 2014.

Before their time at Oxurion NV, Philippe served as the Head of Research & Development at 4C Biotech S.A. from October 2000 to March 2003. Prior to that, they were a Project Lead at Laboratoires SMB from April 1993 to September 2000. Philippe also worked as a Post-Doctoral Researcher at Université catholique de Louvain from October 1991 to March 1993.

Philippe's early career included positions at Université de Namur, where they served as an Assistant Professor from October 1989 to September 1991, and as an I.R.S.I.A. Researcher from January 1985 to September 1989.

Overall, Philippe B. has extensive experience in scientific research and leadership roles within the biotech and pharmaceutical industries.

Philippe B. has a Postdoctoral Researcher experience in Medicinal and Pharmaceutical Chemistry from Université catholique de Louvain. Philippe also holds a Doctor of Science degree in Organic Chemistry and a Master of Science degree in Organic Chemistry, both from Université de Namur.